Tivic Health to acquire nausea treatment products from Reliefband Technologies
seekingalpha.com
finance
2022-10-17 12:53:11

jeffbergen/E+ via Getty Images Health technology company Tivic Health Systems (NASDAQ:TIVC) will acquire the Reliefband product line for nausea treatment and all related assets from Reliefband Technologies. The total consideration is of up to $33.5M, of which up to $1.5M can be paid in restricted common stock. TIVC will also acquire Reliefband's Reletex-branded prescription nausea treatments. Reliefband Technologies' patented products are backed by 40 peer-reviewed clinical studies. The transaction is expected to be consummated in Q4 or Q1 2023.
